These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 34508831)

  • 1. Advances in Understanding of Pathogenesis and Treatment of Immune-Mediated Kidney Disease: A Review.
    Kant S; Kronbichler A; Sharma P; Geetha D
    Am J Kidney Dis; 2022 Apr; 79(4):582-600. PubMed ID: 34508831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of complement in glomerulonephritis-are novel therapies ready for prime time?
    Cheung CK; Dormer JP; Barratt J
    Nephrol Dial Transplant; 2023 Jul; 38(8):1789-1797. PubMed ID: 36307926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What is new in therapy of glomerulonephritis in 2003/2004.
    Hruby Z
    Rocz Akad Med Bialymst; 2004; 49():166-9. PubMed ID: 15631335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted therapy in glomerular diseases.
    Lin YC; Gau TS; Jiang ZH; Chen KY; Tsai YT; Lin KY; Tung HN; Chang FC
    J Formos Med Assoc; 2024 Feb; 123(2):149-158. PubMed ID: 37442744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Executive summary of the KDIGO 2021 Guideline for the Management of Glomerular Diseases.
    Rovin BH; Adler SG; Barratt J; Bridoux F; Burdge KA; Chan TM; Cook HT; Fervenza FC; Gibson KL; Glassock RJ; Jayne DRW; Jha V; Liew A; Liu ZH; Mejía-Vilet JM; Nester CM; Radhakrishnan J; Rave EM; Reich HN; Ronco P; Sanders JF; Sethi S; Suzuki Y; Tang SCW; Tesar V; Vivarelli M; Wetzels JFM; Lytvyn L; Craig JC; Tunnicliffe DJ; Howell M; Tonelli MA; Cheung M; Earley A; Floege J
    Kidney Int; 2021 Oct; 100(4):753-779. PubMed ID: 34556300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Research advances on targeted-Treg therapies on immune-mediated kidney diseases.
    Li Y; Liu H; Yan H; Xiong J
    Autoimmun Rev; 2023 Feb; 22(2):103257. PubMed ID: 36563769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathological spectrum of glomerular disease in patients with renal insufficiency: a single-center study in Northeastern China.
    Chen L; Luodelete M; Dong C; Li B; Zhang W; Nie P; Liu J; Chen X; Luo P
    Ren Fail; 2019 Nov; 41(1):473-480. PubMed ID: 31198075
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of Rare Inflammatory Kidney Diseases: Drugs Targeting the Terminal Complement Pathway.
    Anliker-Ort M; Dingemanse J; van den Anker J; Kaufmann P
    Front Immunol; 2020; 11():599417. PubMed ID: 33362783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Membranous nephropathy with crescents: a series of 19 cases.
    Rodriguez EF; Nasr SH; Larsen CP; Sethi S; Fidler ME; Cornell LD
    Am J Kidney Dis; 2014 Jul; 64(1):66-73. PubMed ID: 24709471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapidly progressive glomerulonephritis due to anti-glomerular basement membrane disease accompanied by IgA nephropathy: An unusual association.
    Annamalai I; Chandramohan G; Srinivasa Prasad ND; Fernando E; Sujith S
    Saudi J Kidney Dis Transpl; 2017; 28(6):1404-1407. PubMed ID: 29265054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetic nephropathy with anti-GBM nephritis.
    Ahuja TS; Velasco A; Deiss W; Indrikovs AJ; Rajaraman S
    Am J Kidney Dis; 1998 Jan; 31(1):127-30. PubMed ID: 9428463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin II Type 1 Receptor Antibodies Are Higher in Lupus Nephritis and Vasculitis than Other Glomerulonephritis Patients.
    Szymczak M; Heidecke H; Żabińska M; Rukasz D; Wiśnicki K; Tukiendorf A; Krajewska M; Banasik M
    Arch Immunol Ther Exp (Warsz); 2022 Sep; 70(1):23. PubMed ID: 36152104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The incidence of renal diseases as diagnosed by biopsy in Hungary].
    Sipiczki T; Ondrik Z; Abrahám G; Pokorny G; Túri S; Sonkodi S; Kemény E; Iványi B
    Orv Hetil; 2004 Jun; 145(26):1373-9. PubMed ID: 15384747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistopathologic evaluation of C1q in 800 renal biopsy specimens.
    Jennette JC; Hipp CG
    Am J Clin Pathol; 1985 Apr; 83(4):415-20. PubMed ID: 3885712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complement Inhibitors in Clinical Trials for Glomerular Diseases.
    Zipfel PF; Wiech T; Rudnick R; Afonso S; Person F; Skerka C
    Front Immunol; 2019; 10():2166. PubMed ID: 31611870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of anti-glomerular basement membrane glomerulonephritis during the course of IgA nephropathy: a case report.
    Kojima T; Hirose G; Komatsu S; Oshima T; Sugisaki K; Tomiyasu T; Yoshikawa N; Yamada M; Oda T
    BMC Nephrol; 2019 Jan; 20(1):25. PubMed ID: 30683055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Membranous nephropathy with crescents.
    Basford AW; Lewis J; Dwyer JP; Fogo AB
    J Am Soc Nephrol; 2011 Oct; 22(10):1804-8. PubMed ID: 21903992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of mycophenolic acid in non-transplant renal diseases.
    Stassen PM; Kallenberg CG; Stegeman CA
    Nephrol Dial Transplant; 2007 Apr; 22(4):1013-9. PubMed ID: 17307748
    [No Abstract]   [Full Text] [Related]  

  • 19. [Expression of neonatal Fc receptor on human nephritis and rat nephritis models].
    Feng ST; Gan HL; Sun JY; Jiang T; Liu BL; Zhao ZH; Guo MY; Zhang ZG
    Zhonghua Bing Li Xue Za Zhi; 2012 Feb; 41(2):81-5. PubMed ID: 22455882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of C4d Immunohistochemistry as an Adjunct Stain in Diagnostic Renal Pathology of Glomerular Diseases.
    Pradeep I; Srinivas BH
    Int J Surg Pathol; 2024 Feb; 32(1):21-26. PubMed ID: 37143311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.